Corporate Responsibility Report

Overview

The report presents Cytokinetics' inaugural corporate responsibility disclosure for 2022, describing a formal materiality assessment and Board-level oversight through the Nominating & Governance Committee. It emphasizes patient-centric clinical development and a high-integrity, diverse and inclusive culture. The report also introduces the company's first GHG emissions disclosure alongside environmental sustainability initiatives for its offices and laboratories.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: Ends 31 December 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services